Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
bioZhena is a private women's health medical technology company developing home-use diagnostic and fertility-monitoring tools centered on its Ovulona product. The company's core technology combines a proprietary tissue biosensor with software/algorithms to track menstrual-cycle physiology and detect or anticipate ovulation. Its positioning extends beyond conception support into broader reproductive health monitoring and physician-facing menstrual-cycle profiling. bioZhena appears to operate as an early-stage, very small medtech company rather than a therapeutics developer, with limited publicly disclosed commercial scale, financing, and organizational detail.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bioZhena.